Pub Date : 2023-10-01DOI: 10.3928/00485713-20230911-03
Thomas J. Spencer, Olivia Descorbeth, Frances R. Levin
Clinical practice guidelines (CPGs) require skilled contributors who may have conflicts of interest (COI) that need to be assessed and managed to minimize possible biased influence. Different organizations have unique COI management policies depending on their available expertise, circumstances, and judgment. To inform the development of the American Professional Society of ADHD and Related Disorders (APSARD) COI management procedures, we reviewed the literature. Because there are no CPGs for adult attention-deficit/hyperactivity disorder (ADHD) in the United States, we reviewed COI management policies of related CPGs with a focus on ADHD. There were many common elements, including matching levels of permitted involvement with type of COI. Examples included withdrawals from industry activities and limitations on participation in discussions, deliberations, and/or voting on specific matters. Due to the complexities of COIs, it is impossible to fully operationalize COI management. Ultimately, management of COIs is determined after review by the co-chairs and steering committee in discussion with the task force member. [ Psychiatr Ann . 2023;53(10):455–460.]
{"title":"Conflict of Interest Management in Adult Attention-Deficit/Hyperactivity Disorder Clinical Practice Guidelines","authors":"Thomas J. Spencer, Olivia Descorbeth, Frances R. Levin","doi":"10.3928/00485713-20230911-03","DOIUrl":"https://doi.org/10.3928/00485713-20230911-03","url":null,"abstract":"Clinical practice guidelines (CPGs) require skilled contributors who may have conflicts of interest (COI) that need to be assessed and managed to minimize possible biased influence. Different organizations have unique COI management policies depending on their available expertise, circumstances, and judgment. To inform the development of the American Professional Society of ADHD and Related Disorders (APSARD) COI management procedures, we reviewed the literature. Because there are no CPGs for adult attention-deficit/hyperactivity disorder (ADHD) in the United States, we reviewed COI management policies of related CPGs with a focus on ADHD. There were many common elements, including matching levels of permitted involvement with type of COI. Examples included withdrawals from industry activities and limitations on participation in discussions, deliberations, and/or voting on specific matters. Due to the complexities of COIs, it is impossible to fully operationalize COI management. Ultimately, management of COIs is determined after review by the co-chairs and steering committee in discussion with the task force member. [ Psychiatr Ann . 2023;53(10):455–460.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"280 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136117408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.3928/00485713-20230911-04
Ann Childress, Maggie Sibley, Mary V. Solanto, Max Wiznitzer, Jeffrey H. Newcorn
Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder that begins in childhood and frequently persists into adulthood. During the past two decades, impairment from persisting ADHD symptoms has increasingly been recognized, and along with it, an increase in the number of adults being diagnosed and treated. Medication treatment of adults with ADHD can decrease the long-term negative impact of ADHD symptoms and behavioral interventions can improve executive function. Educational interventions designed to improve clinician knowledge and practice toward ADHD have been shown to be effective. However, although there are professional guidelines for the assessment and treatment of ADHD in children and adolescents in the United States (US), there are no guidelines for adults. This is increasingly problematic given the large number of adults being diagnosed and treated, and the range of professionals offering this treatment. The development of US guidelines for ADHD offers the potential to improve healthcare outcomes by standardizing care among clinicians with differing levels of expertise. [ Psychiatr Ann . 2023;53(10):461–469.]
{"title":"Guidelines in the United States for the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Why They Are Needed","authors":"Ann Childress, Maggie Sibley, Mary V. Solanto, Max Wiznitzer, Jeffrey H. Newcorn","doi":"10.3928/00485713-20230911-04","DOIUrl":"https://doi.org/10.3928/00485713-20230911-04","url":null,"abstract":"Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder that begins in childhood and frequently persists into adulthood. During the past two decades, impairment from persisting ADHD symptoms has increasingly been recognized, and along with it, an increase in the number of adults being diagnosed and treated. Medication treatment of adults with ADHD can decrease the long-term negative impact of ADHD symptoms and behavioral interventions can improve executive function. Educational interventions designed to improve clinician knowledge and practice toward ADHD have been shown to be effective. However, although there are professional guidelines for the assessment and treatment of ADHD in children and adolescents in the United States (US), there are no guidelines for adults. This is increasingly problematic given the large number of adults being diagnosed and treated, and the range of professionals offering this treatment. The development of US guidelines for ADHD offers the potential to improve healthcare outcomes by standardizing care among clinicians with differing levels of expertise. [ Psychiatr Ann . 2023;53(10):461–469.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"2015 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135655640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.3928/00485713-20230907-01
Yu-Shiuan Liaw, Yin-Ju Lien
Individuals with schizophrenia often experience poor psychosocial outcomes and self-stigma. This study aimed to investigate the effect of compensatory cognitive training (CCT) on self-esteem, self-efficacy, quality of life, and self-stigma in schizophrenia. Forty-six participants with schizophrenia were randomly assigned to intervention (CCT group, n = 24) or treatment as usual (TAU group, n = 22). The Rosenberg Self-Esteem Scale (RSES), the General Self-Efficacy Scale (GSES), the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4), and the Internalized Stigma of Mental Illness Scale (ISMIS) were administered at pretest (T0), posttest (T1), and 1-month follow-up (T2). A significant result was found at T2 in the SQLS-R4 score between CCT and TAU groups ( P = 0.001). A significant result was also noted at T2 in the ISMIS score ( P = 0.004). These findings show that CCT contributes to improvement in quality of life and self-stigma in individuals with schizophrenia. Accordingly, CCT may enhance the effectiveness of psychiatric rehabilitation programs. [ Psychiatr Ann . 2023;53(10):473–481.]
{"title":"Compensatory Cognitive Training for Psychosocial Outcomes and Self-Stigma in Individuals With Schizophrenia: A Randomized Controlled Trial Study","authors":"Yu-Shiuan Liaw, Yin-Ju Lien","doi":"10.3928/00485713-20230907-01","DOIUrl":"https://doi.org/10.3928/00485713-20230907-01","url":null,"abstract":"Individuals with schizophrenia often experience poor psychosocial outcomes and self-stigma. This study aimed to investigate the effect of compensatory cognitive training (CCT) on self-esteem, self-efficacy, quality of life, and self-stigma in schizophrenia. Forty-six participants with schizophrenia were randomly assigned to intervention (CCT group, n = 24) or treatment as usual (TAU group, n = 22). The Rosenberg Self-Esteem Scale (RSES), the General Self-Efficacy Scale (GSES), the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4), and the Internalized Stigma of Mental Illness Scale (ISMIS) were administered at pretest (T0), posttest (T1), and 1-month follow-up (T2). A significant result was found at T2 in the SQLS-R4 score between CCT and TAU groups ( P = 0.001). A significant result was also noted at T2 in the ISMIS score ( P = 0.004). These findings show that CCT contributes to improvement in quality of life and self-stigma in individuals with schizophrenia. Accordingly, CCT may enhance the effectiveness of psychiatric rehabilitation programs. [ Psychiatr Ann . 2023;53(10):473–481.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135655642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.3928/00485713-20230824-02
Fatma Tuygar Okutucu
DiGeorge syndrome (DGS), known as 22q11.2 deletion syndrome or velocardiofacial syndrome, is one of the most common microdeletion syndromes in humans. Developmental delay, intellectual disability, congenital cardiac and gross vessel anomalies, hypocalcemia, and hearing loss may be seen and characterized by dysmorphic facial features. The syndrome has high risk for psychiatric disorders, specifically intellectual disability and psychotic disorders. Dysmorphic features may be overlooked and the diagnosis may be delayed for years. We explore a case of DGS with intellectual disability and atypical psychotic symptoms. A 19-year-old female patient had atypical psychotic symptoms, dysmorphic facial features, and unilateral hearing loss. Intellectual disability was detected in the IQ test evaluation. A detailed investigation and genetic evaluation resulted in a diagnosis of DGS. This case report highlights the variable clinical presentation of DGS in each patient and the need for a multidisciplinary methodology to diagnose and treat it. [ Psychiatr Ann . 2023;53(9):432–435.]
{"title":"DiGeorge Syndrome With Atypical Psychotic Symptoms: The Need for a Multidisciplinary Methodology","authors":"Fatma Tuygar Okutucu","doi":"10.3928/00485713-20230824-02","DOIUrl":"https://doi.org/10.3928/00485713-20230824-02","url":null,"abstract":"DiGeorge syndrome (DGS), known as 22q11.2 deletion syndrome or velocardiofacial syndrome, is one of the most common microdeletion syndromes in humans. Developmental delay, intellectual disability, congenital cardiac and gross vessel anomalies, hypocalcemia, and hearing loss may be seen and characterized by dysmorphic facial features. The syndrome has high risk for psychiatric disorders, specifically intellectual disability and psychotic disorders. Dysmorphic features may be overlooked and the diagnosis may be delayed for years. We explore a case of DGS with intellectual disability and atypical psychotic symptoms. A 19-year-old female patient had atypical psychotic symptoms, dysmorphic facial features, and unilateral hearing loss. Intellectual disability was detected in the IQ test evaluation. A detailed investigation and genetic evaluation resulted in a diagnosis of DGS. This case report highlights the variable clinical presentation of DGS in each patient and the need for a multidisciplinary methodology to diagnose and treat it. [ Psychiatr Ann . 2023;53(9):432–435.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"120 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135299034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.3928/00485713-20230806-01
Tülay Yıldırım Üşenmez, Funda Kavak Budak, Mehmet Osman Ayhan
The aim of this study was to evaluate the effect of self-esteem on loneliness in persons with schizophrenia. This study was conducted between August 2020 and August 2021 at a community mental health center affiliated with a research and training hospital in Turkey. This was a cross-sectional study that included 100 individuals with schizophrenia. A Descriptive Characteristics Form (DCF), the Rosenberg Self-Esteem Scale (RSES), and the University of California Los Angeles Loneliness Scale (UCLA-LS) were used for data collection. The individuals' total mean scores were 2.47 ± 1.24 for RSES and 56.42 ± 10.00 for UCLA-LS. A moderate negative correlation was found between these scores ( r = −0.526, P < 0.01). The results revealed that the persons with schizophrenia had a moderate level of self-esteem and a high level of loneliness, possibly indicating that as self-esteem increases, loneliness levels may decrease. [ Psychiatr Ann . 2023;53(9):419–424.]
本研究的目的是评估自尊对精神分裂症患者孤独感的影响。这项研究于2020年8月至2021年8月在土耳其一家研究和培训医院附属的社区精神卫生中心进行。这是一项包括100名精神分裂症患者的横断面研究。采用描述性特征表(DCF)、Rosenberg自尊量表(RSES)和加州大学洛杉矶分校孤独量表(UCLA-LS)进行数据收集。RSES评分为2.47±1.24分，UCLA-LS评分为56.42±10.00分。这些评分之间存在中度负相关(r = - 0.526, P <0.01)。结果显示，精神分裂症患者有中等程度的自尊和高度的孤独感，这可能表明随着自尊的增加，孤独感可能会减少。[精神病医生安。]2023; 53(9): 419 - 424。)
{"title":"The Effect of Self-Esteem on Loneliness in Individuals With Schizophrenia","authors":"Tülay Yıldırım Üşenmez, Funda Kavak Budak, Mehmet Osman Ayhan","doi":"10.3928/00485713-20230806-01","DOIUrl":"https://doi.org/10.3928/00485713-20230806-01","url":null,"abstract":"The aim of this study was to evaluate the effect of self-esteem on loneliness in persons with schizophrenia. This study was conducted between August 2020 and August 2021 at a community mental health center affiliated with a research and training hospital in Turkey. This was a cross-sectional study that included 100 individuals with schizophrenia. A Descriptive Characteristics Form (DCF), the Rosenberg Self-Esteem Scale (RSES), and the University of California Los Angeles Loneliness Scale (UCLA-LS) were used for data collection. The individuals' total mean scores were 2.47 ± 1.24 for RSES and 56.42 ± 10.00 for UCLA-LS. A moderate negative correlation was found between these scores ( r = −0.526, P < 0.01). The results revealed that the persons with schizophrenia had a moderate level of self-esteem and a high level of loneliness, possibly indicating that as self-esteem increases, loneliness levels may decrease. [ Psychiatr Ann . 2023;53(9):419–424.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135298811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.3928/00485713-20230820-02
Dustin DeMoss
Measurement-based care has improved patient health outcomes by adding precision to clinical decision making at the patient level, when implemented correctly, across health care systems. Payors and system administrators also use measurements to assess program performance and inform resource allocation. This article describes frustrations and unintended consequences experienced by patients, psychiatric providers, administrators, and health systems when exuberant measurement, often without clearly stated goals, is promulgated with insufficient consideration as to the purpose, selection, and timing of these measurements by administrators and health systems. We propose some principles to inform when, how, by whom, and what to measure in managing the care of psychiatric patients. [ Psychiatr Ann . 2023;53(9):410–414.]
{"title":"To Measure or Not to Measure: Perspectives of Measurement-Based Care From the Trenches","authors":"Dustin DeMoss","doi":"10.3928/00485713-20230820-02","DOIUrl":"https://doi.org/10.3928/00485713-20230820-02","url":null,"abstract":"Measurement-based care has improved patient health outcomes by adding precision to clinical decision making at the patient level, when implemented correctly, across health care systems. Payors and system administrators also use measurements to assess program performance and inform resource allocation. This article describes frustrations and unintended consequences experienced by patients, psychiatric providers, administrators, and health systems when exuberant measurement, often without clearly stated goals, is promulgated with insufficient consideration as to the purpose, selection, and timing of these measurements by administrators and health systems. We propose some principles to inform when, how, by whom, and what to measure in managing the care of psychiatric patients. [ Psychiatr Ann . 2023;53(9):410–414.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"165 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135889098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.3928/00485713-20230818-01
Robert D. Gibbons, Philip S. Wang
In this article, we compare and contrast mental health measurement based on classical test theory (CTT) with computerized adaptive testing (CAT) based on multidimensional item response theory (MIRT). We show that MIRT-based CAT has numerous advantages over the traditional CTT approach in terms of maximizing the precision of measurement while at the same time decreasing the burden of measurement both for the clinician and patient. We review the literature on CAT for depression, anxiety, mania/hypomania, posttraumatic stress disorder, suicidality psychosis, and substance use disorders. We highlight two interesting applications, one for national prevalence determination, and one for student mental health. Applications to special populations where item-level bias may exist and integration with electronic medical records systems are also discussed. [ Psychiatr Ann . 2023;53(9):400–404.]
{"title":"The Science of Psychiatric Measurement","authors":"Robert D. Gibbons, Philip S. Wang","doi":"10.3928/00485713-20230818-01","DOIUrl":"https://doi.org/10.3928/00485713-20230818-01","url":null,"abstract":"In this article, we compare and contrast mental health measurement based on classical test theory (CTT) with computerized adaptive testing (CAT) based on multidimensional item response theory (MIRT). We show that MIRT-based CAT has numerous advantages over the traditional CTT approach in terms of maximizing the precision of measurement while at the same time decreasing the burden of measurement both for the clinician and patient. We review the literature on CAT for depression, anxiety, mania/hypomania, posttraumatic stress disorder, suicidality psychosis, and substance use disorders. We highlight two interesting applications, one for national prevalence determination, and one for student mental health. Applications to special populations where item-level bias may exist and integration with electronic medical records systems are also discussed. [ Psychiatr Ann . 2023;53(9):400–404.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135889100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.3928/00485713-20230720-01
Hasan Bakay, Sakir Gica, Esra Cinar Tanriverdi, Mine Sahingoz
Vaccination has played an important role in combating the spread of the COVID-19 virus. The aim of the study is to investigate the effects of personality traits that may be associated with COVID-19 vaccine hesitancy. The study included 468 participants. A sociodemographic data form and Eysenck Personality Questionnaire Revised – Abbreviated Form (EPQR-A) were filled out via an online survey. The mean score of the EPQR-A psychoticism and lie subscales were significantly higher in unvaccinated participants. Further analyses revealed that having psychoticism personality and lying explicitly predicted the probability of being unvaccinated. These results suggest that there is a relationship between personality characteristics and attitude towards vaccination. Our findings may guide health care professionals and policy makers in achieving herd immunity. [ Psychiatr Ann . 2023;53(9):425–431.]
{"title":"Examination of Personality Traits in Predicting COVID-19 Vaccine Hesitancy: A Community-Based Survey Study","authors":"Hasan Bakay, Sakir Gica, Esra Cinar Tanriverdi, Mine Sahingoz","doi":"10.3928/00485713-20230720-01","DOIUrl":"https://doi.org/10.3928/00485713-20230720-01","url":null,"abstract":"Vaccination has played an important role in combating the spread of the COVID-19 virus. The aim of the study is to investigate the effects of personality traits that may be associated with COVID-19 vaccine hesitancy. The study included 468 participants. A sociodemographic data form and Eysenck Personality Questionnaire Revised – Abbreviated Form (EPQR-A) were filled out via an online survey. The mean score of the EPQR-A psychoticism and lie subscales were significantly higher in unvaccinated participants. Further analyses revealed that having psychoticism personality and lying explicitly predicted the probability of being unvaccinated. These results suggest that there is a relationship between personality characteristics and attitude towards vaccination. Our findings may guide health care professionals and policy makers in achieving herd immunity. [ Psychiatr Ann . 2023;53(9):425–431.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135299032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.3928/00485713-20230828-03
Andrew A. Nierenberg
{"title":"Suicide on the Rise","authors":"Andrew A. Nierenberg","doi":"10.3928/00485713-20230828-03","DOIUrl":"https://doi.org/10.3928/00485713-20230828-03","url":null,"abstract":"","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135299023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：